Bio Plus Co., Ltd

KOSDAQ:A099430 Stock Report

Market Cap: ₩399.1b

Bio Plus Dividends and Buybacks

Dividend criteria checks 1/6

Bio Plus is a dividend paying company with a current yield of 0.74% that is well covered by earnings.

Key information

0.7%

Dividend yield

1.3%

Buyback Yield

Total Shareholder Yield2.0%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio15%

Recent dividend and buyback updates

Recent updates

What Bio Plus Co., Ltd's (KOSDAQ:099430) 26% Share Price Gain Is Not Telling You

May 09
What Bio Plus Co., Ltd's (KOSDAQ:099430) 26% Share Price Gain Is Not Telling You

Bio Plus' (KOSDAQ:099430) Anemic Earnings Might Be Worse Than You Think

Mar 31
Bio Plus' (KOSDAQ:099430) Anemic Earnings Might Be Worse Than You Think

Does Bio Plus (KOSDAQ:099430) Have A Healthy Balance Sheet?

Feb 14
Does Bio Plus (KOSDAQ:099430) Have A Healthy Balance Sheet?

Bio Plus Co., Ltd's (KOSDAQ:099430) Shares Climb 30% But Its Business Is Yet to Catch Up

Jan 07
Bio Plus Co., Ltd's (KOSDAQ:099430) Shares Climb 30% But Its Business Is Yet to Catch Up

Bio Plus (KOSDAQ:099430) Is Reinvesting At Lower Rates Of Return

Dec 15
Bio Plus (KOSDAQ:099430) Is Reinvesting At Lower Rates Of Return

Bio Plus Co., Ltd's (KOSDAQ:099430) Shareholders Might Be Looking For Exit

Nov 23
Bio Plus Co., Ltd's (KOSDAQ:099430) Shareholders Might Be Looking For Exit

Earnings Not Telling The Story For Bio Plus Co., Ltd (KOSDAQ:099430) After Shares Rise 29%

Jul 23
Earnings Not Telling The Story For Bio Plus Co., Ltd (KOSDAQ:099430) After Shares Rise 29%

The Returns On Capital At Bio Plus (KOSDAQ:099430) Don't Inspire Confidence

Jul 05
The Returns On Capital At Bio Plus (KOSDAQ:099430) Don't Inspire Confidence

More Unpleasant Surprises Could Be In Store For Bio Plus Co., Ltd's (KOSDAQ:099430) Shares After Tumbling 31%

Jun 08
More Unpleasant Surprises Could Be In Store For Bio Plus Co., Ltd's (KOSDAQ:099430) Shares After Tumbling 31%

Additional Considerations Required While Assessing Bio Plus' (KOSDAQ:099430) Strong Earnings

Mar 26
Additional Considerations Required While Assessing Bio Plus' (KOSDAQ:099430) Strong Earnings

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A099430 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: A099430 has only been paying a dividend for 2 years, and since then payments have fallen.


Dividend Yield vs Market

Bio Plus Dividend Yield vs Market
How does A099430 dividend yield compare to the market?
SegmentDividend Yield
Company (A099430)0.7%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)3.7%
Industry Average (Medical Equipment)0.8%
Analyst forecast (A099430) (up to 3 years)n/a

Notable Dividend: A099430's dividend (0.74%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.17%).

High Dividend: A099430's dividend (0.74%) is low compared to the top 25% of dividend payers in the KR market (3.75%).


Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (14.5%), A099430's dividend payments are thoroughly covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: A099430 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/05 15:03
End of Day Share Price 2025/06/05 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bio Plus Co., Ltd is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hyung Soo KimHanwha Investment & Securities Co., Ltd.
Junghyun KimKyobo Securities Co., Ltd
Jaehee WonShinhan Investment Corp.